Poseida Therapeutics Presents on the Development of Allogeneic and Autologous BCMA-Specific CAR-T Therapies at … – GlobeNewswire (press release)
|
Poseida Therapeutics Presents on the Development of Allogeneic and Autologous BCMA-Specific CAR–T Therapies at …
GlobeNewswire (press release) SAN DIEGO, Nov. 14, 2017 (GLOBE NEWSWIRE) — Poseida Therapeutics, Inc. (“Poseida”), a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, will participate today in a presentation on the … |
